Patents by Inventor Mewes Bottner

Mewes Bottner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8685704
    Abstract: The invention relates to an isolated genetically modified microorganism in which the gene IDH1 and at least one of the genes SDH2 and DIC1 are under the control of a first promoter that is repressed to a growth culture medium by means of a cultivation additive and is active in the absence of the cultivation additive. The genes that are part of the group comprising “PYC1, ACS1, CIT1, ACO1, ICL1, MSL1, and CIT2, optionally also MDH3” are constitutively active. The invention further relates to uses of such a microorganism, especially for producing succinic acid.
    Type: Grant
    Filed: April 16, 2008
    Date of Patent: April 1, 2014
    Assignee: Organo-Balance GmbH
    Inventors: Christine Lang, Markus Veen, Mewes Bottner, Andreas Raab
  • Patent number: 8506953
    Abstract: Described is a microorganism belonging to the group of lactic acid bacteria which is able to drastically reduce the peptide concentration in saliva thereby depleting the substrate used by anaerobic microorganisms of the oral micro-flora which are the causative agent for oral malodour. Moreover, described is a microorganism belonging to the group of lactic acid bacteria which is able to stimulate the growth of Streptococcus salivarius but does not stimulate the growth of Streptococcus mutans and/or Porphyromonas gingivalis. Also described are compositions containing the above-mentioned microorganisms, their use for preventing and/or treating oral malodour and/or halitosis and to methods for preventing and/or treating oral malodour and/or halitosis.
    Type: Grant
    Filed: May 19, 2009
    Date of Patent: August 13, 2013
    Assignee: BASF SE
    Inventors: Mewes Böttner, Christine Lang, Markus Veen, Michael Schilling, Andreas Reindl
  • Publication number: 20120020942
    Abstract: The invention concerns new isolated Lactobacillus cells, which are capable of aggregating Helicobacter pylori under culture conditions of the human digestive tract, in particular of the stomach, and to the uses of such cells.
    Type: Application
    Filed: October 12, 2006
    Publication date: January 26, 2012
    Applicant: Organobalance, GMBH
    Inventors: Mewes Bottner, Eckhard Budde, Christine Lang, Martin Ryser, Markus Veen
  • Publication number: 20110129885
    Abstract: The invention relates to an isolated genetically modified microorganism in which the gene IDH1 and at least one of the genes SDH2 and DIC1 are under the control of a first promoter that is repressed to a growth culture medium by means of a cultivation additive and is active in the absence of the cultivation additive. The genes that are part of the group comprising “PYC1, ACS1, CIT1, ACO1, ICL1, MSL1, and CIT2, optionally also MDH3” are constitutively active. The invention further relates to uses of such a microorganism, especially for producing succinic acid.
    Type: Application
    Filed: April 16, 2008
    Publication date: June 2, 2011
    Applicant: ORGANO-BALANCE GMBH
    Inventors: Christine Lang, Markus Veen, Mewes Böttner, Andreas Raab
  • Publication number: 20110117068
    Abstract: Described are microorganism which are able to reduce the generation of feces odor by decreasing the amount of at least one of the compounds methyl mercaptan, a sulphide compound, cadavarine, putrescine, indole or skatole, and wherein said decrease in the amount of said compounds is independent of the growth of the microorganism. Also described are compositions, comprising such microorganisms, e.g. food, feed or pharmaceutical compositions and the use of such microorganisms for suppressing feces odor or the preparation of foodstuff or feedstuff, as well as corresponding methods for the production of food or feed composition and additives for food, feed or drinks.
    Type: Application
    Filed: August 20, 2007
    Publication date: May 19, 2011
    Applicant: OrganoBalance GmbH
    Inventors: Christine Lang, Stefanie Arya, Natalia Bolotina, Markus Veen, Mewes Böttner, Eckhard Budde, Andreas Künkel, Angelika-Maria Pfeiffer
  • Publication number: 20110097284
    Abstract: Described is a microorganism belonging to the group of lactic acid bacteria which is able to drastically reduce the peptide concentration in saliva thereby depleting the substrate used by anaerobic microorganisms of the oral micro-flora which are the causative agent for oral malodour. Moreover, described is a microorganism belonging to the group of lactic acid bacteria which is able to stimulate the growth of Streptococcus salivarius but does not stimulate the growth of Streptococcus mutans and/or Porphyromonas gingivalis. Also described are compositions containing the above-mentioned microorganisms, their use for preventing and/or treating oral malodour and/or halitosis and to methods for preventing and/or treating oral malodour and/or halitosis.
    Type: Application
    Filed: May 19, 2009
    Publication date: April 28, 2011
    Applicant: BASF SE
    Inventors: Mewes Böttner, Christine Lang, Markus Veen, Michael Schilling, Andreas Reindl